By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oncobiologics Inc.  

7 Clarke Drive

Cranbury  New Jersey  08512  U.S.A.
Phone: 609-619-3990 Fax: 609-619-3980


SEARCH JOBS


Industry
Biotechnology






Company News
Oncobiologics (ONSIU) Announces Term Extension Of Series A Warrants 2/7/2017 11:05:41 AM
Oncobiologics (ONSIU) Release: Biopharma Issues Remaining Senior Secured Notes And Warrants–Raising An Aggregate $10.0 Million 1/11/2017 7:19:20 AM
Oncobiologics (ONSIU) Issues $8.35 Million Of Senior Secured Notes And Warrants To Acquire 1.9 Million Shares As Part Of Aggregate $10.0 Million Note And 2.3 Million Warrant Offering 12/27/2016 8:05:30 AM
Oncobiologics (ONSIU) Announces Presentation Of Final Data From Phase I Clinical Study Of ONS-3010 (HUMIRA Biosimilar) 11/14/2016 7:45:27 AM
Oncobiologics (ONSIU) To Present At Biocentury’s Newsmakers In The Biotech Industry Conference 9/1/2016 8:25:28 AM
Oncobiologics Announces Pricing Of Its Initial Public Offering Of Units 5/13/2016 6:38:30 AM
Premier, Inc. And Oncobiologics Align To Advance Adoption Of Biosimilar Drugs 3/3/2016 10:35:56 AM
Oncobiologics Expands Its Board Of Directors With The Appointment Of Three New Independent Members 12/14/2015 8:00:15 AM
Oncobiologics Announces ONS-1045 (Avastin/bevacizumab biosimilar) Meets Primary And Secondary Endpoints In Phase 1 Clinical Trial 10/5/2015 6:14:12 AM
Oncobiologics Secures Financing From Sabby Management, LLC, To Advance BioSymphony Platform And Monoclonal Antibody Biosimilars Pipeline 9/29/2015 6:39:22 AM
123
//-->